Compagnie Lombard Odier SCmA Makes New Investment in American Well Co. (NYSE:AMWL)

Compagnie Lombard Odier SCmA purchased a new stake in shares of American Well Co. (NYSE:AMWL) during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 6,150 shares of the company’s stock, valued at approximately $45,000.

Several other hedge funds and other institutional investors also recently made changes to their positions in AMWL. HighTower Advisors LLC acquired a new stake in American Well during the 3rd quarter worth approximately $355,000. Walleye Capital LLC bought a new position in shares of American Well during the third quarter valued at $167,000. PDT Partners LLC acquired a new position in shares of American Well during the third quarter worth $107,000. Finally, BNP Paribas Financial Markets bought a new stake in shares of American Well in the third quarter worth $95,000. 56.05% of the stock is currently owned by institutional investors.

American Well Stock Up 3.7 %

Shares of AMWL stock opened at $12.17 on Friday. The firm has a 50 day moving average of $9.26 and a 200-day moving average of $9.14. The company has a market cap of $186.37 million, a price-to-earnings ratio of -0.83 and a beta of 1.18. American Well Co. has a 52 week low of $5.00 and a 52 week high of $29.00.

American Well (NYSE:AMWL) last posted its quarterly earnings results on Wednesday, February 12th. The company reported ($2.77) EPS for the quarter, topping analysts’ consensus estimates of ($3.04) by $0.27. American Well had a negative net margin of 84.27% and a negative return on equity of 52.49%. Analysts anticipate that American Well Co. will post -13.38 earnings per share for the current year.

Analyst Ratings Changes

AMWL has been the topic of several recent research reports. Needham & Company LLC reaffirmed a “hold” rating on shares of American Well in a report on Thursday. Stifel Nicolaus upped their target price on American Well from $9.00 to $10.00 and gave the company a “hold” rating in a report on Thursday. Morgan Stanley lowered their price target on shares of American Well from $20.00 to $10.50 and set an “equal weight” rating for the company in a report on Tuesday, December 17th. Wells Fargo & Company upgraded shares of American Well from an “equal weight” rating to an “overweight” rating and set a $15.00 price objective for the company in a research report on Monday, January 13th. Finally, Truist Financial boosted their target price on shares of American Well from $10.00 to $12.00 and gave the company a “hold” rating in a report on Friday. Five analysts have rated the stock with a hold rating and one has assigned a buy rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $11.90.

About American Well

American Well Corporation, an enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally. The company offers Converge, a cloud-based platform that enables health providers, payers, and innovators to provide in-person, virtual and automated care; and delivers virtual primary care, post-discharge follow-up, chronic condition management, virtual nursing, e-sitting, on-demand and scheduled virtual visits, specialty consults, automated care, and behavioral health, as well as specialty care programs, including dermatology, musculoskeletal care, second opinion, and cardiometabolic care to patients and members.